Advertisement

Topics

David Elliott Company Profile

02:56 EDT 21st June 2018 | BioPortfolio


News Articles [389 Associated News Articles listed on BioPortfolio]

Elliott Management Outlines Concerns With athenahealth’s Lack of Engagement Over Acquisition Bid in Letter

On Tuesday, Elliott Management Corporation (“Elliott”) released a letter to the Board of Directors of athenahealth, Inc. regarding Elliott’s proposal to acquire athenahealth for $160 per share ...

Elliott Squires is recognized by Continental Who's Who

GREENVILLE, N.C., April 2, 2018/PRNewswire/ -- Elliott Squiresis recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Read more...

Will athenahealth accept Elliott Management’s hefty buyout offer?

After Elliott Management sent a third letter to athenahealth urging it to consider the offer, the EHR vendor retorted with a statement of its own, noting it will take its time in evaluating the bid.

Elliott Management Makes $7 Billion Takeover Offer for athenahealth

Investment firm Elliott Management has proposed acquiring Watertown, Mass.-based health IT vendor athenahealth in a deal worth nearly $7 billion.

Activist investor Elliott Management makes $6.9B unsolicited offer for athenahealth

In a letter to athenahealth’s board of directors, Elliott Management Partner Jesse Cohn makes his firm’s case for why the company would be better off as a private business.

STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG 12.01.2018 / 15:21 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this...

Elliott makes $7B all-cash bid for Athenahealth

Elliott makes $7B all-cash bid for Athenahealth nleider Mon, 05/07/2018 - 14:44 Teaser Media

Correction of a release from 12.01.2018, 15:21 CET/CEST - STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG 29.01.2018 / 15:04 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this...

PubMed Articles [49 Associated PubMed Articles listed on BioPortfolio]

Correction to: Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.

In the original version of this article, author Ryan Elliott's name was misspelled as Ryan Eliott. The correct spelling of the name is Ryan Elliott.

Correction to: The Impact of Religiosity on Substance Abuse and Obesity in African Americans.

The original version of this article unfortunately contained a mistake in the author names. The co-author names should be David Meetze and Ronald Whicker Jr. instead of David Meetz and Ronald Wicker. ...

Rapid regeneration offsets losses from warming-induced tree mortality in an aspen-dominated broad-leaved forest in northern China.

Worldwide tree mortality as induced by climate change presents a challenge to forest managers. To successfully manage vulnerable forests requires the capacity of regeneration to compensate for losses ...

David E. Kuhl, MD.

Video Comment on David J. Tate et al.

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

Brain Development Research Program

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of...

Training Therapy for the Prevention of Back Pain

Work place related (lower) back pain in medical personnel is limiting to workability. Even though occupational prevention programs are increasingly established, data on the effectiveness ...

A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

A multi-center, placebo controlled, double-blind trial comparing the efficacy and safety of 18 months of treatment with deferiprone versus placebo in patients with PKAN. This investigator...

CAMS-RAS: for Suicide Prevention

The overarching goal of this research is to create a tool that could reduce suicide rates, increase delivery of efficacious suicide interventions, and decrease overall costs associated wit...

Narrative Comprehension by People With Acquired Brain Injury

The purpose of this two phase study is to evaluate comprehension by people with acquired brain injury. The phase 1 portion of the study will examine comprehension of narrative paragraphs u...

Companies [169 Associated Companies listed on BioPortfolio]

FS-Elliott

FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air compressors with operations in over 90 countries. Building on a 50-year tradition o...

David Elliott

David Elliott Healing

DAVID Corporation

DAVID Corporation, a pioneer in the alternative-risk market, has been providing business-improving services and process-automating software for more than a quarter of century. DAV...

Elliott Advisors

More Information about "David Elliott" on BioPortfolio

We have published hundreds of David Elliott news stories on BioPortfolio along with dozens of David Elliott Clinical Trials and PubMed Articles about David Elliott for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of David Elliott Companies in our database. You can also find out about relevant David Elliott Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record